Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells

Cancer Research

Volumn 57, Issue 8, 1997, Pages 1590-1596

  Dairkee, Shanaz H ^a,c   Paulo, Eileen C ^a   Traquina, Pedro ^a   Moore, Dan H ^a   Ljung, Britt Marie ^b   Smith, Helene S ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Geraldine Brush Cancer Res Inst   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; GENE PRODUCT; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CANCER CELL CULTURE; CELL INVASION; CELL PROLIFERATION; CLINICAL PROTOCOL; CONNECTIVE TISSUE; CONTROLLED STUDY; ENZYME DEGRADATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; STROMA;

EID: 0030937486     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Fournier, D. V., Weber, E., and Hoeffken, W. Growth rate of 147 mammary carcinomas. Cancer (Phila.), 45: 2198-2207, 1980.
2. Smith, H. S. In vitro models in human breast cancer. In: J. R. Harris, S. Hellman, I. C. Henderson, and D. W. Kinne (eds.), Breast Diseases, pp. 181-189, Philadelphia: J. B. Lippincott, 1991.
3. Smith, H. S., Dairkee, S. H., Ljung, B-M., Mayall, B., Sylvester, S. S., and Hackett, A. J. cellular manifestations of breast cancer. In: D. Medina, W. Kidwell, G. Heppner, and E. Anderson (eds.), Cellular and Molecular Biology of Mammary Cancer, pp. 437-452. New York: Plenum Publishing Corp., 1987.
4. Ljung, B-M., Mayall, B., Lottich, C., Boyer, C., Sylvester, S., Leight, G., Siegler, H. F., and Smith, H. S. Cell dissociation techniques in human breast cancer: variations in tumor cell viability and DNA ploidy. Breast Cancer Res. Treat., 13: 153-159, 1989.
5. Besch, G. J., Wolberg, W. H., Gilchrist, K. W., Voelkel, J. G., and Gould, M. N. A comparison of methods for the production of monodispersed cell suspensions from human primary breast carcinomas. Breast Cancer Res. Treat., 3: 15-22, 1983.
6. Wolman, S. R., Smith, H. S., Stampfer, M. S., and Hackett, A. J. Growth of diploid cells from breast cancers. Cancer Genet. Cytogenet., 16: 49-64, 1985.
7. Gusterson, B. A., Warburton, M. J., Mitchell, D., Ellison, M., Neville, A. M., and Rudland, P. S. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res., 42: 4763-4768, 1982.
8. Barsky, S. H., Siegal, G. P., Janotta, F., and Liotta, L. A. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab. Invest., 49: 140-145, 1983.
9. Liotta, L. A. Tumor invasion and metastases: role of basement membrane. Am. J. Pathol., 117: 339-349, 1984.
10. Ethier, S. P., Mahacek, M. L., Gullick, W. J., Frank, T. S., and Weber, B. L. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res., 53: 627-635, 1993.
11. Kallioniemi, O-P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., and Gray, J. Erb-B2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA, 89: 5321-5325, 1992.
12. Dairkee, S. H., Deng, G., Stampfer, M. R. Waldman, F. M., and Smith, H. S. Selective cell culture of primary breast carcinoma. Cancer Res., 55: 2516-2519, 1995.
13. Teixeira, M. R., Pandis, N., Bardi, G., Andersen, J. A., and Heim, S. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res., 56: 855-859, 1996.
14. Nordquist, R. E., Ishmael, D. R., Lovig, C. A., Hyder, D. M., and Hoge, A. F. The tissue culture and morphology of human breast tumor cell line BOT-2. Cancer Res., 35: 3100-3105, 1975.
15. Lasfargues, E. Y., Coutinho, W. G., and Redfield, E. S. Isolation of two human tumor epithelial cell lines from solid breast carcinomas. J. Natl. Cancer Inst., 61: 967-978, 1978.
16. Langlois, A. J., Holder, W. D., Jr., Iglehart, J. D., Nelson-Rees, W. A., Wells, S. A., Jr., and Bolognesi, D. P. Morphological and biochemical properties of a new human breast cancer cell line. Cancer Res., 39: 2604-2613, 1979.
17. Petersen, O. W., van Deurs, B., Nielsen, K., Madsen, M. W., Laursen, I., Balslev, I., and Briand, P. Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-39095 1 and HMT-390958, established in serum-free medium. Cancer Res., 50: 1257-1270, 1990.
18. Band, V., Zajchowski, D., Swisshelm, D., Trask, D., Kulesa V., Cohen, C., Conolly, J., and Sager, R. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res., 50: 7351-7357, 1990.
19. Meltzer, P., Leibovitz, A., Dalton, W., Villar, H., Kute, T., Davis, J., Nagle, R., and Trent, J. Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br. J. Cancer, 63: 727-735, 1991.
20. Klaus, M. H., Popescu, N. C., Amsbaugh, S. C., and King, C. R. Overexpression of the EGF-receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J., 6: 605-610, 1987.
21. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and Mcguire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
22. van de Vijver, M. J., Petersen, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O., and Nusse, R. Neu-protein overexpression in breast cancer. N. Engl. J. Med., 319: 1239-1245, 1988.
23. Thor, A. D., Moore, D. H., II, Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, M. T. Marcus, J. N., Schwanz, L., Chen, L. C. and Mayall, B. H. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers, J. Natl. Cancer Inst., 84: 845-855, 1992.
24. Momand, J., Zambetti, G. P., Olsen, D. C., Gearge, D., and Levine, A. J. The indin-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237-1245, 1992.
25. Wynford-Thomas, D. p53 in tumor pathology: can we trust immuno-cytochemistry? J. Pathol., 166: 329-330, 1992.
26. Delmolino, L., Band, H., and Band, V. Expression and stability of p53 protein in normal human mammary epithelial cells. Carcinogenesis (Lond.), 14: 827-832, 1993.
27. Lehman, T. A., Modali, R., Boukamp, P., Stanek, J., Bennett, W. P., Welsh, J. A., Metcalf, R. A., Stampfen M. R., Fusenig, N., Rogan, E. M., and Harris, C. C. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis (Lond.), 14: 833-839, 1993.
28. Gudas, J. M., Oka, M.. Diella, F., Trepel, J., and Cowan, K. H. Expression of wild-type p53 during the cell cycle in normal human mammary epithelial cells. Cell Growth & Differ., 5: 295-304, 1994.
29. Hellemans, P., van Dam, P. A., Weyler, J., van Oosterom, A. T., Buytaert, P., and Van Marck, E. Prognostic value of bcl-2 expression in invasive breast cancer. Br. J. Cancer, 72: 354-360, 1995.
30. Nathan, B., Gusterson, B., Jadayel, D., O'Hare, M., Anbazhagan, R., Jayatilake, H., Ebbs, S., Micklem, K., Price, K., and Gelber, R. Expression of bcl-2 in primary breast cancer and its correlation with tumor phenotype. Annals Oncol., 5: 409-414, 1994.
31. Gee, J. M., Robertson, J. F., Ellis, I. O., Willsher, P., McClelland, R. A., Hoyle, H. B., Kyme, S. R., Finlay, P., Blarney, R. W., and Nicholson, R. I. Immunocytochemical localization of bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int. J. Cancer, 59: 619-628, 1994.
32. Sabourin, J. C., Martin, A., Baruch, J., True, J. B., Gompel, A., and Poitout, P. bcl-2 expression in normal breast tissue during the menstrual cycle. Int. J. Cancer, 59: 1-6, 1994.
33. Lu, Q. L., Hanby, A. M., Nasser Hajibagheri M. A., Gschmeissner, S. E., Lu, P. J., Taylor-Papadiniitriou, J., Krajewski S., Reed, J. C., and Wright, N. A. bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J. Cell Sci., 707: 363-371, 1994.